Identification of a Prevalent Nonsense Mutation (W283X) and Two Novel Mutations in the Porphobilinogen Deaminase Gene of Swiss Patients with Acute Intermittent Porphyria
Authors:
- Catherine BogardCBCatherine Bogard
- Ursula B. RüfenachtURUrsula B. Rüfenacht
- Hervé PuyHPHervé Puy
- Yves NordmannYNYves Nordmann
- Elisabeth I. MinderEMElisabeth I. Minder
- Jean-Charles DeybachJDJean-Charles Deybach
- 1 April 2000
- journal article
- Published by S. Karger AG in Human Heredity
- Vol. 50 (4) , 247-250
Abstract
Acute intermittent porphyria (AIP) is an autosomal dominant disorder caused by decreased activity of porphobilinogen deaminase (PBGD), the third enzyme in the heme biosynthetic pathway. We report the first molecular analysis of PBGD gene mutations in AIP patients of Swiss origin. The PBGD gene of 18 Swiss AIP patients was analyzed by denaturing gradient gel electrophoresis screening of the genomic DNA and direct sequencing. Thirteen of the 18 patients (72%) carried a nonsense mutation G849→A, W283X. In addition, 4 different mutations including 2 novel mutations (Q217L and Q292X), were identified in the 5 remaining AIP patients originating from both German- and Italian-speaking regions of Switzerland.Keywords
This publication has 1 reference indexed in Scilit: